Effect of the Administration of Alpha-Lipoic Acid on Contrast Sensitivity in Patients with Type 1 and Type 2 Diabetes
The aim of this study was to estimate the effects of oral supplementation of alpha-lipoic acid (ALA) on contrast sensitivity (CS) in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). The study included 12 patients with T1DM aged 43±12 years, 48 patients with T2DM age...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2014/131538 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850218275078668288 |
|---|---|
| author | Anna Gębka Ewelina Serkies-Minuth Dorota Raczyńska |
| author_facet | Anna Gębka Ewelina Serkies-Minuth Dorota Raczyńska |
| author_sort | Anna Gębka |
| collection | DOAJ |
| description | The aim of this study was to estimate the effects of oral supplementation of alpha-lipoic acid (ALA) on contrast sensitivity (CS) in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). The study included 12 patients with T1DM aged 43±12 years, 48 patients with T2DM aged 59±10 years, and 20 control subjects aged 33±8 years. Patients from each studied group, including the control group, were randomly assigned to receive 300 mg of ALA orally once daily for 3 months. CS was evaluated with the Functional Acuity Contrast Test (FACT, Stereo Optical). In the group of patients with T1DM receiving ALA for 3 months CS remained stable and improved in those with T2DM. Reduction of CS in both T1DM and T2DM patients without alpha-lipoic acid supplementation was observed. In the control group on alpha-lipoic acid supplementation, CS improvement was noticed at one spatial frequency. Changes in the CS were observed, despite stable visual acuity and eye fundus image in all studied subjects. Our study demonstrated that oral administration of alpha-lipoic acid had influence on CS in both T1DM and T2DM patients. |
| format | Article |
| id | doaj-art-3d6aaaffbd35408ca12d11db36170a21 |
| institution | OA Journals |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-3d6aaaffbd35408ca12d11db36170a212025-08-20T02:07:48ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/131538131538Effect of the Administration of Alpha-Lipoic Acid on Contrast Sensitivity in Patients with Type 1 and Type 2 DiabetesAnna Gębka0Ewelina Serkies-Minuth1Dorota Raczyńska2Department of Ophthalmology, Medical University of Gdańsk, Smoluchowskiego 17, 80-214 Gdańsk, PolandDepartment of Ophthalmology, Medical University of Gdańsk, Smoluchowskiego 17, 80-214 Gdańsk, PolandDepartment of Ophthalmology, Medical University of Gdańsk, Smoluchowskiego 17, 80-214 Gdańsk, PolandThe aim of this study was to estimate the effects of oral supplementation of alpha-lipoic acid (ALA) on contrast sensitivity (CS) in patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). The study included 12 patients with T1DM aged 43±12 years, 48 patients with T2DM aged 59±10 years, and 20 control subjects aged 33±8 years. Patients from each studied group, including the control group, were randomly assigned to receive 300 mg of ALA orally once daily for 3 months. CS was evaluated with the Functional Acuity Contrast Test (FACT, Stereo Optical). In the group of patients with T1DM receiving ALA for 3 months CS remained stable and improved in those with T2DM. Reduction of CS in both T1DM and T2DM patients without alpha-lipoic acid supplementation was observed. In the control group on alpha-lipoic acid supplementation, CS improvement was noticed at one spatial frequency. Changes in the CS were observed, despite stable visual acuity and eye fundus image in all studied subjects. Our study demonstrated that oral administration of alpha-lipoic acid had influence on CS in both T1DM and T2DM patients.http://dx.doi.org/10.1155/2014/131538 |
| spellingShingle | Anna Gębka Ewelina Serkies-Minuth Dorota Raczyńska Effect of the Administration of Alpha-Lipoic Acid on Contrast Sensitivity in Patients with Type 1 and Type 2 Diabetes Mediators of Inflammation |
| title | Effect of the Administration of Alpha-Lipoic Acid on Contrast Sensitivity in Patients with Type 1 and Type 2 Diabetes |
| title_full | Effect of the Administration of Alpha-Lipoic Acid on Contrast Sensitivity in Patients with Type 1 and Type 2 Diabetes |
| title_fullStr | Effect of the Administration of Alpha-Lipoic Acid on Contrast Sensitivity in Patients with Type 1 and Type 2 Diabetes |
| title_full_unstemmed | Effect of the Administration of Alpha-Lipoic Acid on Contrast Sensitivity in Patients with Type 1 and Type 2 Diabetes |
| title_short | Effect of the Administration of Alpha-Lipoic Acid on Contrast Sensitivity in Patients with Type 1 and Type 2 Diabetes |
| title_sort | effect of the administration of alpha lipoic acid on contrast sensitivity in patients with type 1 and type 2 diabetes |
| url | http://dx.doi.org/10.1155/2014/131538 |
| work_keys_str_mv | AT annagebka effectoftheadministrationofalphalipoicacidoncontrastsensitivityinpatientswithtype1andtype2diabetes AT ewelinaserkiesminuth effectoftheadministrationofalphalipoicacidoncontrastsensitivityinpatientswithtype1andtype2diabetes AT dorotaraczynska effectoftheadministrationofalphalipoicacidoncontrastsensitivityinpatientswithtype1andtype2diabetes |